Evidence map›Paper›PMID 34601942›Full record

ArticleCirculation. Genomic and precision medicine2021

Genome-Wide Association Study of Peripheral Artery Disease.

Natalie R van Zuydam, Alexander Stiby, Moustafa Abdalla, Erin Austin, Emma H Dahlström, Stela McLachlan, Efthymia Vlachopoulou, Emma Ahlqvist, Chen Di Liao, Niina Sandholm and 23 more

Open access · hybridAbstract read
In one paragraph

Article in Circulation. Genomic and precision medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 82 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors at 13 institutions in 8 countries.

Natalie R van Zuydam *Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden (N.R.v.Z.).ORCID 0000-0002-9809-1398
Alexander Stiby *Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (A.S., J.C.H.), University of Oxford, United Kingdom.
Moustafa AbdallaWellcome Centre for Human Genetics, Nuffield Department of Medicine (N.R.v.Z., M.A., A.M., N.R.R., N.W.R., M.I.M., A.P.M.), University of Oxford, United Kingdom.ORCID 0000-0002-2481-9753
Erin AustinDepartment of Cardiovascular Medicine and the Gonda Vascular Center, Mayo Clinic, Rochester, MN (E. Austin, M.d.A., I.J.K.).ORCID 0000-0002-2709-8699
Emma H DahlströmFolkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland (E.H.D., N.S., C.F., P.-H.G.).ORCID 0000-0002-9809-1398
Stela McLachlanUsher Institute of Population Health Sciences and Informatics, The University of Edinburgh, United Kingdom (S.M., E.W., J.P.).
Efthymia VlachopoulouDepartment of Medicine, Helsinki University Central Hospital (E.V.), University of Helsinki, Finland.
Emma AhlqvistGenomics, Diabetes and Endocrinology, Lund University Diabetes Centre, Malmö, Sweden (E. Ahlqvist, E.L., L.G.).ORCID 0000-0002-6513-2384
Chen Di LiaoDalla Lana School of Public Health, University of Toronto, ON, Canada (C.D.L., A.P.).ORCID 0000-0001-9469-205X
Niina SandholmFolkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland (E.H.D., N.S., C.F., P.-H.G.).ORCID 0000-0003-4322-6942
Carol ForsblomFolkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland (E.H.D., N.S., C.F., P.-H.G.).ORCID 0000-0002-3354-7454
Anubha MahajanWellcome Centre for Human Genetics, Nuffield Department of Medicine (N.R.v.Z., M.A., A.M., N.R.R., N.W.R., M.I.M., A.P.M.), University of Oxford, United Kingdom.
Neil R RobertsonWellcome Centre for Human Genetics, Nuffield Department of Medicine (N.R.v.Z., M.A., A.M., N.R.R., N.W.R., M.I.M., A.P.M.), University of Oxford, United Kingdom.
N William RaynerWellcome Centre for Human Genetics, Nuffield Department of Medicine (N.R.v.Z., M.A., A.M., N.R.R., N.W.R., M.I.M., A.P.M.), University of Oxford, United Kingdom.ORCID 0000-0003-0510-4792
Eero LindholmGenomics, Diabetes and Endocrinology, Lund University Diabetes Centre, Malmö, Sweden (E. Ahlqvist, E.L., L.G.).ORCID 0000-0002-8869-681X
Juha SinisaloHeart and Lung Center (J.S.), University of Helsinki, Finland.ORCID 0000-0002-0169-5137
Markus PerolaInstitute for Molecular Medicine Finland (FIMM) (M.P., L.G.), University of Helsinki, Finland.ORCID 0000-0003-4842-1667
Milla KallioVascular Surgery, Abdominal Center (M.K.), University of Helsinki, Finland.ORCID 0000-0001-7215-5202
Emily WeissUsher Institute of Population Health Sciences and Informatics, The University of Edinburgh, United Kingdom (S.M., E.W., J.P.).ORCID 0000-0001-9903-7222
Jackie PriceUsher Institute of Population Health Sciences and Informatics, The University of Edinburgh, United Kingdom (S.M., E.W., J.P.).
Andrew PatersonDalla Lana School of Public Health, University of Toronto, ON, Canada (C.D.L., A.P.).ORCID 0000-0002-9169-118X
Barbara KleinOcular Epidemiology Research Group, University of Wisconsin-Madison (B.K.).
Veikko SalomaaFinnish Institute for Health and Welfare, Helsinki, Finland (M.P., V.S.).ORCID 0000-0001-7563-5324
Colin N A PalmerPat Macpherson Centre for Pharmacogenetics and Pharmacogenomics, Ninewells Hospital and Medical School, University of Dundee, United Kingdom (C.N.A.P.).ORCID 0000-0002-6415-6560
Per-Henrik GroopFolkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland (E.H.D., N.S., C.F., P.-H.G.).
Leif GroopInstitute for Molecular Medicine Finland (FIMM) (M.P., L.G.), University of Helsinki, Finland.
Mark I McCarthyWellcome Centre for Human Genetics, Nuffield Department of Medicine (N.R.v.Z., M.A., A.M., N.R.R., N.W.R., M.I.M., A.P.M.), University of Oxford, United Kingdom.ORCID 0000-0002-4393-0510
Mariza de AndradeDepartment of Cardiovascular Medicine and the Gonda Vascular Center, Mayo Clinic, Rochester, MN (E. Austin, M.d.A., I.J.K.).ORCID 0000-0003-2329-2686
Andrew P MorrisWellcome Centre for Human Genetics, Nuffield Department of Medicine (N.R.v.Z., M.A., A.M., N.R.R., N.W.R., M.I.M., A.P.M.), University of Oxford, United Kingdom.
Jemma C Hopewell *Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (A.S., J.C.H.), University of Oxford, United Kingdom.ORCID 0000-0002-3870-8018
Helen M Colhoun *Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital Campus, United Kingdom (H.M.C.).ORCID 0000-0002-8345-3288
Iftikhar J Kullo *Department of Cardiovascular Medicine and the Gonda Vascular Center, Mayo Clinic, Rochester, MN (E. Austin, M.d.A., I.J.K.).ORCID 0000-0002-6524-3471
GoLEAD Consortium, SUMMIT Consortium†
Centre for Human Genetics · GBUniversity of Helsinki · FILund University · SEMayo Clinic · USUniversity of Edinburgh · GBFinnish Institute for Health and Welfare · FINuffield Health · GBPublic Health Ontario · CAUniversity of Wisconsin–Madison · USWestern General Hospital · GBHelsinki University Hospital · FINinewells Hospital · GBOxford Centre for Diabetes, Endocrinology and Metabolism · GB

Funding

Integrating genome-scale data to reveal causal mechanisms in type 2 diabetesU01DK105535 · NIDDK · UNIVERSITY OF OXFORD · PI GLOYN, ANNA LOUISE · 2015 to 2019
$1.7M
British Heart Foundation CH/1996001/9454British Heart Foundation FS/14/55/30806Cancer Research UK 16896Medical Research Council MC_PC_17228Medical Research Council MC_QA137853NIDDK NIH HHS U01 DK105535Wellcome Trust 076113Wellcome Trust 090532Wellcome Trust 098381Wellcome Trust 203141Wellcome Trust 212259
6 · The paper itself

Abstract

backgroundPeripheral artery disease (PAD) affects >200 million people worldwide and is associated with high mortality and morbidity. We sought to identify genomic variants associated with PAD overall and in the contexts of diabetes and smoking status.

methodsWe identified genetic variants associated with PAD and then meta-analyzed with published summary statistics from the Million Veterans Program and UK Biobank to replicate their findings. Next, we ran stratified genome-wide association analysis in ever smokers, never smokers, individuals with diabetes, and individuals with no history of diabetes and corresponding interaction analyses, to identify variants that modify the risk of PAD by diabetic or smoking status.

resultsWe identified 5 genome-wide significant (

conclusionsOur analyses confirm the published genetic associations with PAD and identify novel variants that may influence susceptibility to PAD in the context of diabetes or smoking status.

Indexed as

Genetic Predisposition to DiseasePolymorphism, Single NucleotideFemaleGenome-Wide Association StudyHumansMalePeripheral Arterial Diseasediabetesgenome-wide association studyperipheral vascular diseasesmoking

Identifiers

PMID34601942
PMCPMC8542067
OpenAlexW3202307311

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.